Acheteur · Autre

European Medicines Agency, MED - European Medicines Agency

Amsterdam · Groot-Amsterdam

Suivre cette ficheCompte gratuit — soyez alerté dès qu’un marché arrive à échéance.

Attributions

33

Montant total attribué

7,5 M €

2 / 33 avec un montant

Titulaires

56

Dernière mise à jour

4 sept. 2026

Titulaires en place

Attributions

AttributionAcheteurTitulaireMontant du marchéPublié le
Data Management- Anonymization and redaction of documents and datasetsEuropean Medicines Agency, MED - European Medicines AgencyIQVIA Solutions Belgium B.V., Syneos Health Clinical Spain, S.L.U.—4 sept. 2026
LOT 7: Computational methods for comparison of molecular structural features in the context of medicines for rare diseasesEuropean Medicines Agency, MED - European Medicines AgencyIstituto di Ricerche Farmacologiche Mario Negri, KREATIS—1 sept. 2026
LOT 6: Innovative technologies for manufacturing and quality control of medicinesEuropean Medicines Agency, MED - European Medicines AgencyNATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING LIMITED, RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH, UNIVERSITA DEGLI STUDI DI MILANO—1 sept. 2026
LOT 5: Pharmacoepidemiological researchEuropean Medicines Agency, MED - European Medicines AgencyAgora Labs S.r.L., Biomedical Research Foundation, Academy of Athens – BRFAA, Certara France SARL +15 autres—1 sept. 2026
LOT 4: Qualitative researchEuropean Medicines Agency, MED - European Medicines AgencyNHG Finland Oy, NIVEL, Oracle France S.A.S. +2 autres—1 sept. 2026
LOT 3: Methodological/statistical researchEuropean Medicines Agency, MED - European Medicines AgencyAgentschap College ter Beoordeling van Geneesmiddelen, Austrian Agency for Health and Food Safety GmbH, Danish medicines Agency +8 autres—1 sept. 2026
LOT 2: Veterinary researchEuropean Medicines Agency, MED - European Medicines AgencyDanish medicines Agency, ECORYS EUROPE EEIG - GEIE, Gent university—1 sept. 2026
LOT 7: Computational methods for comparison of molecular structural features in the context of medicines for rare diseasesEuropean Medicines Agency, MED - European Medicines AgencyIstituto di Ricerche Farmacologiche Mario Negri, KREATIS—9 juil. 2026
LOT 6: Innovative technologies for manufacturing and quality control of medicinesEuropean Medicines Agency, MED - European Medicines AgencyNATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING LIMITED, RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH, UNIVERSITA DEGLI STUDI DI MILANO—9 juil. 2026
LOT 5: Pharmacoepidemiological researchEuropean Medicines Agency, MED - European Medicines AgencyAgora Labs S.r.L., Biomedical Research Foundation, Academy of Athens – BRFAA, Certara France SARL +15 autres—9 juil. 2026
LOT 4: Qualitative researchEuropean Medicines Agency, MED - European Medicines AgencyNHG Finland Oy, NIVEL, Oracle France S.A.S. +2 autres—9 juil. 2026
LOT 3: Methodological/statistical researchEuropean Medicines Agency, MED - European Medicines AgencyAgentschap College ter Beoordeling van Geneesmiddelen, Austrian Agency for Health and Food Safety GmbH, Danish medicines Agency +8 autres—9 juil. 2026
LOT 2: Veterinary researchEuropean Medicines Agency, MED - European Medicines AgencyDanish medicines Agency, ECORYS EUROPE EEIG - GEIE, Gent university—9 juil. 2026
LOT 7: Computational methods for comparison of molecular structural features in the context of medicines for rare diseasesEuropean Medicines Agency, MED - European Medicines AgencyIstituto di Ricerche Farmacologiche Mario Negri, KREATIS—2 juil. 2026
LOT 5: Pharmacoepidemiological researchEuropean Medicines Agency, MED - European Medicines AgencyAgora Labs S.r.L., Biomedical Research Foundation, Academy of Athens – BRFAA, Certara France SARL +15 autres—2 juil. 2026
LOT 4: Qualitative researchEuropean Medicines Agency, MED - European Medicines AgencyNHG Finland Oy, NIVEL, Oracle France S.A.S. +2 autres—2 juil. 2026
LOT 3: Methodological/statistical researchEuropean Medicines Agency, MED - European Medicines AgencyAgentschap College ter Beoordeling van Geneesmiddelen, Austrian Agency for Health and Food Safety GmbH, Danish medicines Agency +8 autres—2 juil. 2026
LOT 2: Veterinary researchEuropean Medicines Agency, MED - European Medicines AgencyDanish medicines Agency, ECORYS EUROPE EEIG - GEIE, Gent university—2 juil. 2026
Services to develop, design and delivery of e-learning in the field of pharmaceutical quality assessmentEuropean Medicines Agency, MED - European Medicines AgencyALT VENTURES (PTY) LTD, Klippe Learning, LATTANZIO KIBS SPA +1 autres—29 juin 2026
Services to develop, design and delivery of e-learning in the field of clinical assessmentEuropean Medicines Agency, MED - European Medicines AgencyLATTANZIO KIBS SPA, PQE, Quamed—6 mai 2026
Services to develop, design and delivery of e-learning in the field of non clinical assessmentEuropean Medicines Agency, MED - European Medicines AgencyGalileo Research srl, LATTANZIO KIBS SPA, PQE—6 mai 2026
Provision of Catering and Hospitality ServicesEuropean Medicines Agency, MED - European Medicines AgencyVermaat Bedrijfshoreca B.V.—1 avr. 2026
Data Management Services-SPOR and Veterinary Medicinal Products Data ManagementEuropean Medicines Agency, MED - European Medicines AgencySyneos Health Clinical Spain, S.L.U.—31 mars 2026
LOT 5: Pharmacoepidemiological researchEuropean Medicines Agency, MED - European Medicines AgencyAgora Labs S.r.L., Biomedical Research Foundation, Academy of Athens – BRFAA, Certara France SARL +15 autres—31 mars 2026
LOT 4: Qualitative researchEuropean Medicines Agency, MED - European Medicines AgencyNHG Finland Oy, NIVEL, Oracle France S.A.S. +2 autres—31 mars 2026
LOT 3: Methodological/statistical researchEuropean Medicines Agency, MED - European Medicines AgencyAgentschap College ter Beoordeling van Geneesmiddelen, Austrian Agency for Health and Food Safety GmbH, Danish medicines Agency +8 autres—31 mars 2026
Data Management Services – EudraVigilance and EurEKAEuropean Medicines Agency, MED - European Medicines AgencyIQVIA Solutions Belgium B.V., Syneos Health Clinical Spain, S.L.U.—19 mars 2026
LOT 4: Qualitative researchEuropean Medicines Agency, MED - European Medicines AgencyNHG Finland Oy, NIVEL, Oracle France S.A.S. +2 autres—15 mars 2026
LOT 3: Methodological/statistical researchEuropean Medicines Agency, MED - European Medicines AgencyAgentschap College ter Beoordeling van Geneesmiddelen, Austrian Agency for Health and Food Safety GmbH, Danish medicines Agency +8 autres—15 mars 2026
Provision of non-residential Property Consultancy and Advice, Property Related Client Representation and Assistance and Ancillary Services related to 30 Churchill Place, Canary Wharf, LondonEuropean Medicines Agency, MED - European Medicines AgencyBNP PARIBAS REAL ESTATE ADVISORY &PROPERTY MANAGEMENT UK LIMITED—18 déc. 2025
Assessment of applications of candidates (LOT 3)European Medicines Agency, MED - European Medicines AgencyCore consulting S.p.A, Hudson Belgium, PwC EU Services EESV European Economic Interest Grouping1 236 200 €10 oct. 2025
(LOT 1) Assessment centres and development centresEuropean Medicines Agency, MED - European Medicines AgencyHudson Belgium, Mercer Italia Srl, PwC EU Services EESV European Economic Interest Grouping6 246 561 €10 oct. 2025
Contract for inhouse social assistance workerEuropean Medicines Agency, MED - European Medicines AgencyNH Mediation, SAMEN IN SPEL—19 juin 2025

Également publié sous

European Medicines Agency, MED - European Medicines Agency · European Medicines Agency